Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
NeuroVive Pharmaceutical AB Year End Report January - December 2019 2020-02-19 16:08
NeuroVive Announces Settlement in Dispute With CicloMulsion AG 2019-12-16 18:33
NeuroVive Pharmaceutical AB Interim Report January - September 2019 2019-11-20 16:38
NeuroVive Pharmaceutical AB Interim Report January - June 2019 2019-08-21 15:24
NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDA 2019-05-10 15:05
NeuroVive Pharmaceutical AB Publishes 2018 Annual Report 2019-03-25 17:58
NeuroVive Receives Vinnova Funding to Support Development of NV354, a Novel Treatment for Genetic Mitochondrial Disorders 2018-11-15 19:37
NeuroVive Reports First NeuroSTAT Clinical Efficacy Signal in TBI 2018-10-04 15:43
NeuroVive Receives Positive FDA Feedback on its NeuroSTAT TBI Development Plan 2018-09-06 15:10
NeuroVive's NVP015 Program Will be Accelerated Through Award of Major Research Grant to Children's Hospital of Philadelphia 2018-08-28 15:21
NeuroVive Pharmaceutical AB Interim Report January - June 2018 2018-08-21 15:22
NeuroVive Out-licenses Targeted LHON Therapy to BridgeBio Pharma's New Subsidiary Fortify Therapeutics 2018-06-19 04:39
NeuroVive Pharmaceutical AB Interim Report January - March 2018 2018-05-22 15:22
NeuroVive Initiates Collaboration With Leading US TBI Research Organization 2018-05-02 15:24
Amendment: Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ) 2018-04-27 20:38
NeuroVive's Partner Yungjin Pharm Completes KL1333 Phase I Study Recruitment 2018-04-17 15:03
NeuroVive Decides on a Rights Issue for Continued Drug Development 2018-02-15 16:18
NeuroVive Reports Breakthrough in Mitochondrial Myopathy Project 2018-01-29 21:05
NeuroVive to Present at the 10th Annual Biotech Showcase Conference 2018-01-03 16:10
NeuroVive Reports Promising Progress in its Clinical Project for Genetic Mitochondrial Diseases, KL1333 2017-12-11 18:56
1 2